Form 4 for BSX Boston Scientific
Accepted 2026-02-03 00:00:00 ET · period of report 2026-02-02 · accession 0001225208-26-001156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-03 | 2026-02-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $25.78 | +95.8K | 1.57M | +6% | +$2.47M |
| DM | 2026-02-03 | 2026-02-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $93.49 | -160.9K | 1.57M | -9% | -$15.04M |
| DM | 2026-02-03 | 2026-02-02 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -95.8K | 98.8K | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | M | A | 49,407 | $24.55 | 1,526,289 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-02 | S | D | 159,701 | $93.49 | 1,411,735 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.985, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2026-02-02 | S | D | 1,200 | $94.06 | 1,571,436 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.00 to $94.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2026-02-02 | M | A | 46,347 | $27.09 | 1,572,636 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-02 | M | D | 46,347 | $0.00 | 231,739 | D | $27.09 · — to 2028-02-15 | 46,347 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-02-02 | M | D | 49,407 | $0.00 | 98,814 | D | $24.55 · — to 2027-02-28 | 49,407 Common Stock | (F5) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |